The global cancer gene therapy market size is expected to reach USD 3.99 billion by 2030, according to a new study by Polaris Market Research. The report “Cancer Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Oncolytic Virotherapy, Gene Transfer); By End-Use (Research Institutes, Biopharma Companies); By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides an analysis of future market growth.
The growing demand for cancer gene therapy in diagnosing diseases is expected to drive industry growth. Furthermore, increasing investment in R&D, technological advancement, well-established infrastructure, and awareness among the people are the major factors driving the demand.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/cancer-gene-therapy-market/request-for-sample
In addition, the growing geriatric population across the countries such as India, Japan, the U.S., and China is likely to positively impact the demand for the treatment over the coming years. Furthermore, with the rising technological advancement in the medical sector with government initiatives, the industry is expected to expand.
The industry was negatively impacted during the COVID-19 pandemic. Hospitals were made available for COVID-19 treatment, thus resulting in the declination of industry, but post-pandemic, it is expected to grow.
Cancer Gene Therapy Market Report Highlights
Polaris Market Research has segmented the cancer gene therapy market report based on therapy, end-use, and region:
Cancer Gene Therapy, Therapy Outlook (Revenue - USD Billion, 2018 - 2030)
Cancer Gene Therapy, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)
Cancer Gene Therapy, Regional Outlook (Revenue - USD Billion, 2018 - 2030)